Diagnosis and management of relapse in acute lymphoblastic leukemia

Research output: Contribution to journalReview article

15 Scopus citations

Abstract

Although the results are steadily improving, the treatment of the child with lymphoblastic leukemia in relapse remains unsatisfactory. Owing to the very nature of relapse, it is highly unlikely that future chemotherapy protocols will provide curative treatment for the majority of patients with recurrent disease. Therefore, the greatest possible emphasis must be given to further improvements and refinements in front-line (initial) therapy so as to prevent relapse from ever occurring. Our goal should be to put the relapse leukemia specialist 'out of business.'

Original languageEnglish (US)
Pages (from-to)971-995
Number of pages25
JournalHematology/Oncology Clinics of North America
Volume4
Issue number5
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Diagnosis and management of relapse in acute lymphoblastic leukemia'. Together they form a unique fingerprint.

  • Cite this